APA

Behdani M., Zeinali S., Karimipour M., Khanahmad H., Schoonooghe S., Aslemarz A., Seyed N., Moazami-Godarzi R., Baniahmad F., Habibi-Anbouhi M., Hassanzadeh-Ghassabeh G. & Muyldermans S. (20130702). Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth. : New biotechnology.

Chicago

Behdani Mahdi, Zeinali Sirous, Karimipour Morteza, Khanahmad Hossein, Schoonooghe Steve, Aslemarz Azam, Seyed Negar, Moazami-Godarzi Reza, Baniahmad Farzad, Habibi-Anbouhi Mahdi, Hassanzadeh-Ghassabeh Gholamreza and Muyldermans Serge. 20130702. Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth. : New biotechnology.

Harvard

Behdani M., Zeinali S., Karimipour M., Khanahmad H., Schoonooghe S., Aslemarz A., Seyed N., Moazami-Godarzi R., Baniahmad F., Habibi-Anbouhi M., Hassanzadeh-Ghassabeh G. and Muyldermans S. (20130702). Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth. : New biotechnology.

MLA

Behdani Mahdi, Zeinali Sirous, Karimipour Morteza, Khanahmad Hossein, Schoonooghe Steve, Aslemarz Azam, Seyed Negar, Moazami-Godarzi Reza, Baniahmad Farzad, Habibi-Anbouhi Mahdi, Hassanzadeh-Ghassabeh Gholamreza and Muyldermans Serge. Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth. : New biotechnology. 20130702.